Drugs / BLI1100-3
last change Jun 2016 re-read 3 minutes ago

BLI1100-3

Developed for
acne
Investigated by
Braintree Laboratories

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02604680 Oct 2015 → Jun 2016 acne Braintree Laboratories Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BLI1100-3 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02604680 ↗
Route Topical “BLI1100-3 Topical gel” NCT02604680 ↗